Anna Tavridou

2.5k total citations
70 papers, 2.0k citations indexed

About

Anna Tavridou is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Anna Tavridou has authored 70 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Surgery. Recurrent topics in Anna Tavridou's work include Pharmacogenetics and Drug Metabolism (12 papers), Lipoproteins and Cardiovascular Health (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Anna Tavridou is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Lipoproteins and Cardiovascular Health (8 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Anna Tavridou collaborates with scholars based in Greece, Netherlands and United Kingdom. Anna Tavridou's co-authors include Vangelis G. Manolopoulos, Georgia Ragia, Konstantinos Arvanitidis, M F Laker, Nigel Unwin, Martin White, R. Bhopal, Ioannis Petridis, Nisar Ahmad and Julie Yallop and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Nature Reviews Drug Discovery.

In The Last Decade

Anna Tavridou

69 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Tavridou Greece 22 526 435 397 371 365 70 2.0k
Eric J. Stanek United States 19 477 0.9× 609 1.4× 292 0.7× 724 2.0× 209 0.6× 58 2.1k
Marcelo Chiara Bertolami Brazil 25 385 0.7× 345 0.8× 131 0.3× 685 1.8× 224 0.6× 71 1.9k
Arlene B. Chapman United States 27 683 1.3× 788 1.8× 352 0.9× 294 0.8× 757 2.1× 89 2.6k
Roberto Padrini Italy 27 275 0.5× 503 1.2× 646 1.6× 343 0.9× 402 1.1× 104 2.7k
Lawrence E. Ramsay United Kingdom 26 616 1.2× 1.0k 2.4× 283 0.7× 516 1.4× 205 0.6× 85 2.7k
P. M. Ridker United States 8 284 0.5× 344 0.8× 516 1.3× 149 0.4× 168 0.5× 9 1.4k
José Pablo Werba Italy 26 312 0.6× 496 1.1× 123 0.3× 357 1.0× 212 0.6× 70 1.7k
Andrew D. Morris United Kingdom 25 1.1k 2.1× 259 0.6× 144 0.4× 711 1.9× 822 2.3× 35 2.3k
Jason L. Vassy United States 31 1.2k 2.3× 365 0.8× 134 0.3× 527 1.4× 791 2.2× 90 3.7k
Eugen Steiner Sweden 16 1.1k 2.1× 500 1.1× 370 0.9× 980 2.6× 234 0.6× 25 2.3k

Countries citing papers authored by Anna Tavridou

Since Specialization
Citations

This map shows the geographic impact of Anna Tavridou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Tavridou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Tavridou more than expected).

Fields of papers citing papers by Anna Tavridou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Tavridou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Tavridou. The network helps show where Anna Tavridou may publish in the future.

Co-authorship network of co-authors of Anna Tavridou

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Tavridou. A scholar is included among the top collaborators of Anna Tavridou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Tavridou. Anna Tavridou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ragia, Georgia, et al.. (2019). Association study of the CTH 1364 G>T polymorphism with coronary artery disease in the Greek population. Drug Metabolism and Personalized Therapy. 34(1). 6 indexed citations
2.
Paraskakis, Emmanouil, et al.. (2016). Endothelial nitric oxide synthase gene polymorphisms are associated with sensitization to seasonal aeroallergens in asthmatic children. World Journal of Pediatrics. 13(1). 34–40. 4 indexed citations
3.
Ragia, Georgia, et al.. (2015). Gene-gene interaction of μ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect. Drug Metabolism and Personalized Therapy. 30(2). 129–135. 5 indexed citations
4.
Drosos, Ioannis, Anna Tavridou, & George Kolios. (2015). New Aspects on the Metabolic role of Intestinal Microbiota in the Development of Atherosclerosis. Metabolism. 64(4). 476–481. 57 indexed citations
5.
Ragia, Georgia, Vana Kolovou, Anna Tavridou, et al.. (2014). No effect of CYP3A4 intron 6 C>T polymorphism ( CYP3A4 *22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemia. Drug Metabolism and Personalized Therapy. 30(1). 43–48. 18 indexed citations
6.
Ragia, Georgia, et al.. (2014). Frequency of CYP450 enzyme gene polymorphisms in the Greek population: review of the literature, original findings and clinical significance. Drug metabolism and drug interactions. 29(4). 235–248. 13 indexed citations
7.
Stathias, Vasileios, Iordanis Karagiannidis, Dimitrios Papazoglou, et al.. (2012). Exploring Genomic Structure Differences and Similarities between the Greek and European HapMap Populations: Implications for Association Studies. Annals of Human Genetics. 76(6). 472–483. 7 indexed citations
8.
Ragia, Georgia, et al.. (2012). Association of monocyte chemoattractant protein-1 −2518A>G polymorphism with occurrence, severity, and outcome in ischemic stroke. Neurological Sciences. 34(8). 1315–1320. 8 indexed citations
9.
Tavridou, Anna, et al.. (2011). Association of VKORC1 −1639 G>A polymorphism with carotid intima–media thickness in type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 94(2). 236–241. 17 indexed citations
10.
Tavridou, Anna, Georgia Ragia, & Vangelis G. Manolopoulos. (2011). Emerging Targets for the Treatment of Dyslipidemia. Current Medicinal Chemistry. 18(6). 909–922. 10 indexed citations
11.
Tavridou, Anna, Ioannis Petridis, Konstantinos Arvanitidis, et al.. (2009). The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes. Clinica Chimica Acta. 411(3-4). 167–171. 48 indexed citations
12.
Tavridou, Anna, et al.. (2009). EP2300 Compounds: Focusing on the Antiatherosclerotic Properties of Squalene Synthase Inhibitors. Current Pharmaceutical Design. 15(27). 3167–3178. 9 indexed citations
13.
Stakos, Dimitrios, Anna Tavridou, Dimitrios Margaritis, et al.. (2009). Oxidised low‐density lipoprotein and arterial function in β‐thalassemia major. European Journal Of Haematology. 82(6). 477–483. 11 indexed citations
14.
Tavridou, Anna, et al.. (2008). Novel Molecules Targeting Dyslipidemia and Atherosclerosis. Current Medicinal Chemistry. 15(8). 792–802. 21 indexed citations
15.
16.
Tavridou, Anna, Loukas Kaklamanis, Αpostolos Papalois, et al.. (2007). EP2306 [2-(4-Biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], A Novel Squalene Synthase Inhibitor, Reduces Atherosclerosis in the Cholesterol-Fed Rabbit. Journal of Pharmacology and Experimental Therapeutics. 323(3). 794–804. 18 indexed citations
17.
Vryonidou, Andromachi, et al.. (2005). Association of Hyperandrogenemic and Metabolic Phenotype with Carotid Intima-Media Thickness in Young Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism. 90(5). 2740–2746. 124 indexed citations
18.
Tavridou, Anna & M F Laker. (1999). Field Inversion Gel Electrophoresis for Apolipoprotein(a) Genotyping. Analytical Biochemistry. 272(2). 282–285. 2 indexed citations
19.
Bhopal, R., Nigel Unwin, Martin White, et al.. (1999). Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ. 319(7204). 215–220. 458 indexed citations
20.
Tavridou, Anna, Nigel Unwin, M F Laker, Martin White, & K. G. M. M. Alberti. (1997). Serum concentrations of vitamins A and E in impaired glucose tolerance. Clinica Chimica Acta. 266(2). 129–140. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric J. Stanek Breakdown of academic impact, for papers by Marcelo Chiara Bertolami Breakdown of academic impact, for papers by Arlene B. Chapman Breakdown of academic impact, for papers by Roberto Padrini Breakdown of academic impact, for papers by Lawrence E. Ramsay Breakdown of academic impact, for papers by P. M. Ridker Breakdown of academic impact, for papers by José Pablo Werba Breakdown of academic impact, for papers by Andrew D. Morris Breakdown of academic impact, for papers by Jason L. Vassy Breakdown of academic impact, for papers by Eugen Steiner
Rankless by CCL
2026